These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 26153451)

  • 21. Revisiting the role of glycosylation in the structure of human IgG Fc.
    Borrok MJ; Jung ST; Kang TH; Monzingo AF; Georgiou G
    ACS Chem Biol; 2012 Sep; 7(9):1596-602. PubMed ID: 22747430
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isolation and characterization of IgG1 with asymmetrical Fc glycosylation.
    Ha S; Ou Y; Vlasak J; Li Y; Wang S; Vo K; Du Y; Mach A; Fang Y; Zhang N
    Glycobiology; 2011 Aug; 21(8):1087-96. PubMed ID: 21470983
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hinge-Deficient IgG1 Fc Fusion: Application to Human Lactoferrin.
    Shiga Y; Murata D; Sugimoto A; Oshima Y; Tada M; Ishii-Watabe A; Imai K; Tomii K; Takeuchi T; Kagaya S; Sato A
    Mol Pharm; 2017 Sep; 14(9):3025-3035. PubMed ID: 28763236
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Crystal Structure of a Homogeneous IgG-Fc Glycoform with the N-Glycan Designed to Maximize the Antibody Dependent Cellular Cytotoxicity.
    Chen CL; Hsu JC; Lin CW; Wang CH; Tsai MH; Wu CY; Wong CH; Ma C
    ACS Chem Biol; 2017 May; 12(5):1335-1345. PubMed ID: 28318221
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Conformational Plasticity of the Immunoglobulin Fc Domain in Solution.
    Remesh SG; Armstrong AA; Mahan AD; Luo J; Hammel M
    Structure; 2018 Jul; 26(7):1007-1014.e2. PubMed ID: 29731233
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular aspects of human FcgammaR interactions with IgG: functional and therapeutic consequences.
    Sibéril S; Dutertre CA; Boix C; Bonnin E; Ménez R; Stura E; Jorieux S; Fridman WH; Teillaud JL
    Immunol Lett; 2006 Aug; 106(2):111-8. PubMed ID: 16797726
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IgG-Fc-mediated effector functions: molecular definition of interaction sites for effector ligands and the role of glycosylation.
    Jefferis R; Lund J; Pound JD
    Immunol Rev; 1998 Jun; 163():59-76. PubMed ID: 9700502
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation between CD16a binding and immuno effector functionality of an antigen specific immunoglobulin Fc fragment (Fcab).
    Kainer M; Antes B; Wiederkum S; Wozniak-Knopp G; Bauer A; Rüker F; Woisetschläger M
    Arch Biochem Biophys; 2012 Oct; 526(2):154-8. PubMed ID: 22634259
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunoglobulin G1 Fc domain motions: implications for Fc engineering.
    Frank M; Walker RC; Lanzilotta WN; Prestegard JH; Barb AW
    J Mol Biol; 2014 Apr; 426(8):1799-811. PubMed ID: 24522230
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aglycosylated full-length IgG antibodies: steps toward next-generation immunotherapeutics.
    Ju MS; Jung ST
    Curr Opin Biotechnol; 2014 Dec; 30():128-39. PubMed ID: 25035939
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A variant human IgG1-Fc mediates improved ADCC.
    Stewart R; Thom G; Levens M; Güler-Gane G; Holgate R; Rudd PM; Webster C; Jermutus L; Lund J
    Protein Eng Des Sel; 2011 Sep; 24(9):671-8. PubMed ID: 21596686
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fc Engineering of Human IgG1 for Altered Binding to the Neonatal Fc Receptor Affects Fc Effector Functions.
    Grevys A; Bern M; Foss S; Bratlie DB; Moen A; Gunnarsen KS; Aase A; Michaelsen TE; Sandlie I; Andersen JT
    J Immunol; 2015 Jun; 194(11):5497-508. PubMed ID: 25904551
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interaction sites on human IgG-Fc for FcgammaR: current models.
    Jefferis R; Lund J
    Immunol Lett; 2002 Jun; 82(1-2):57-65. PubMed ID: 12008035
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glycoform-dependent conformational alteration of the Fc region of human immunoglobulin G1 as revealed by NMR spectroscopy.
    Yamaguchi Y; Nishimura M; Nagano M; Yagi H; Sasakawa H; Uchida K; Shitara K; Kato K
    Biochim Biophys Acta; 2006 Apr; 1760(4):693-700. PubMed ID: 16343775
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural analysis of human IgG-Fc glycoforms reveals a correlation between glycosylation and structural integrity.
    Krapp S; Mimura Y; Jefferis R; Huber R; Sondermann P
    J Mol Biol; 2003 Jan; 325(5):979-89. PubMed ID: 12527303
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Method to Detect the Binding of Hyper-Glycosylated Fragment Crystallizable (Fc) Region of Human IgG1 to Glycan Receptors.
    Blundell P; Pleass R
    Methods Mol Biol; 2019; 1904():417-421. PubMed ID: 30539483
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structural characterization of anti-inflammatory immunoglobulin G Fc proteins.
    Ahmed AA; Giddens J; Pincetic A; Lomino JV; Ravetch JV; Wang LX; Bjorkman PJ
    J Mol Biol; 2014 Sep; 426(18):3166-3179. PubMed ID: 25036289
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structural determinants of unique properties of human IgG4-Fc.
    Davies AM; Rispens T; Ooijevaar-de Heer P; Gould HJ; Jefferis R; Aalberse RC; Sutton BJ
    J Mol Biol; 2014 Feb; 426(3):630-44. PubMed ID: 24211234
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An "Fc-Silenced" IgG1 Format With Extended Half-Life Designed for Improved Stability.
    Borrok MJ; Mody N; Lu X; Kuhn ML; Wu H; Dall'Acqua WF; Tsui P
    J Pharm Sci; 2017 Apr; 106(4):1008-1017. PubMed ID: 28057542
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiparallel conformation of knob and hole aglycosylated half-antibody homodimers is mediated by a CH2-CH3 hydrophobic interaction.
    Elliott JM; Ultsch M; Lee J; Tong R; Takeda K; Spiess C; Eigenbrot C; Scheer JM
    J Mol Biol; 2014 May; 426(9):1947-57. PubMed ID: 24576605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.